Medical information Clinical review pending

Cytogenetics

FISH for Pre or Postnatal Diagnosis Chromosome 13 22

This test uses Fluorescence In Situ Hybridization (FISH) to detect potential abnormalities in chromosomes 13 and 22 before or after birth. It helps identify conditions like Trisomy 13 and Trisomy 22.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Prenatal: Amniotic fluid or Chorionic Villus Sample (CVS). Postnatal: Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is typically required for the patient. For prenatal testing, specific collection procedures apply. Confirm with the laboratory before booking.

Test priceKSh 14,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FISH for Pre or Postnatal Diagnosis Chromosome 13 22 test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Prenatal screening for suspected chromosomal abnormalities
✓Postnatal diagnosis of developmental delays or congenital anomalies
✓Advanced maternal age (over 35)
✓Family history of chromosomal disorders
✓Abnormal results from other prenatal screening tests
✓Previous pregnancy affected by chromosomal abnormalities

In plain language

What this test helps you understand

This test helps detect aneuploidy (an abnormal number of chromosomes) involving chromosomes 13 and 22. Identifying these abnormalities can provide crucial information for prenatal counseling, pregnancy management, and postnatal care.

The FISH (Fluorescence In Situ Hybridization) test for Chromosome 13 and 22 is a specialized diagnostic tool used during pregnancy (prenatal) or after birth (postnatal). It helps identify specific chromosomal abnormalities, such as having an extra copy of chromosome 13 (Trisomy 13) or chromosome 22 (Trisomy 22). These conditions can affect a baby's health and development. Early detection allows healthcare providers to offer appropriate guidance and support to families. This test is particularly relevant in cytogenetics and reproductive medicine.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is typically required for the patient. For prenatal testing, specific collection procedures apply. Confirm with the laboratory before booking.

SamplePrenatal: Amniotic fluid or Chorionic Villus Sample (CVS). Postnatal: Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.

MethodologyFluorescence In Situ Hybridization (FISH). This technique uses fluorescent probes that bind to specific parts of the chromosomes, allowing visualization of their number and structure under a microscope.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test only detects abnormalities in chromosomes 13 and 22. It does not screen for other chromosomal abnormalities or genetic conditions. Results may be affected by sample quality. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

FISH stands for Fluorescence In Situ Hybridization. It's a laboratory technique that uses fluorescent dyes to detect specific genetic material, like chromosomes, within cells.

Abnormalities in these chromosomes, such as Trisomy 13 or Trisomy 22, can lead to significant health issues. This test helps identify these specific conditions.

This test is typically recommended for individuals with specific risk factors or concerning findings from other tests. Discuss with your doctor if this test is appropriate for you.

Your doctor will discuss the results with you, explain what they mean, and recommend any necessary follow-up steps or consultations with specialists.

For prenatal testing, samples are collected via procedures like amniocentesis or CVS. For postnatal testing, a blood sample is usually taken. Your doctor will guide you on the collection process.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp